Pharmaceutical Technology - October 2020

PharmTech - Regulatory Sourcebook - October

Issue link: https://www.e-digitaleditions.com/i/1302985

Contents of this Issue

Navigation

Page 13 of 75

14 Pharmaceutical Technology Regulatory Sourcebook October 2020 P h a r mTe c h . c o m Process Development Table VIII. Critical quality attribute (CQA) failure and critical process parameter (CPP) correlation for continued process verificatIion for a freeze-dried product. CQA failure CPP to be monitored Compounding and filling Freezing Primary drying Secondary drying Appearance of the cake • Incomplete solubilization of ingredients (type of stirrer, time and temperature) • Irregular filling • Incomplete solidification (time and/ or temperature) • Non flat lyo trays (if applicable) • Freezing rate • Incomplete drying (time and/or temperature) • Rate of heating too high (product temperature exceeds maximum allowable temperature) • Loss of vacuum • Non flat lyo trays (if applicable) • Incomplete drying (time and/or temperature) • Rate of heating too high (for amorphous systems) Assay • Incomplete solubilization of the API (type of stirrer, time and temperature) • API degradation during compounding, including freeze-dryer loading (time and temperature) • Inadequate order of addition of components • Irregular filling • Freezing rate (especially for proteins) • Rate of heating too high (product temperature exceeds maximum allowable temperature) • Incomplete drying (time and/or temperature) • Incomplete drying (time and or temperature) • Temperature too high Degradation products • API degradation during compounding, including freeze-dryer loading (time and temperature) • Inadequate order of addition of components • Freezing rate (especially for proteins) • Rate of heating too high (product temperature exceeds maximum allowable temperature) • Incomplete drying (time and or temperature) • Temperature too high Uniformity of dosage units • Incomplete solubilization of the API • Irregular filling No impact No impact No impact Residual moisture Low probability and impact Low probability and impact Low probability and impact • Insufficient secondary drying (time and/or temperature) • Product water re- adsorption before water content analysis Polymorphism (solid state of the cake) Low probability and impact • Freezing rate • Annealing (Yes/No, temperature and ramp rate) • Heating rate • Product temperature Reconstitution time and appearance of reconstituted solution • Incomplete solubilization of ingredients (type of stirrer, time, and temperature) • Freezing rate (e.g., re-crystallization) • Temperature and rate of heating too high (product temperature exceeds maximum allowable temperature resulting in collapse, melting, crust formation) Low probability and impact pH of reconstituted solution • Incomplete solubilization of ingredients (type of stirrer, time, and temperature) • Freezing rate (e.g., pH shift) Low impact Low probability and impact Particulate matter • Incomplete solubilization of ingredients (type of stirrer, time, and temperature) • Re-crystallization • Freezing rate (e.g., re-crystallization) • Temperature and rate of heating too high (product temperature exceeds maximum allowable temperature resulting in collapse, melting, crust formation) Low probability and impact

Articles in this issue

Links on this page

Archives of this issue

view archives of Pharmaceutical Technology - October 2020 - PharmTech - Regulatory Sourcebook - October